Chandrasekhar Udata Selected Research

RN909

11/2018

Single and multiple ascending-dose study of glucagon-receptor antagonist RN909 in type 2 diabetes: a phase 1, randomized, double-blind, placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chandrasekhar Udata Research Topics

Disease

2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 12/2019
1	Hypertension (High Blood Pressure) 01/2020
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Diarrhea 11/2018
1	Type 2 Diabetes Mellitus (MODY) 11/2018
1	Atherosclerosis 06/2009
1	Neoplasms (Cancer) 03/2004
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2004
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2004

Drug/Important Bio-Agent (IBA)

2	monoclonal antibody RN168IBA 01/2020 - 12/2019
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 01/2020
1	LDL Receptors (LDL Receptor)IBA 01/2020
1	ApolipoproteinsIBA 01/2020
1	Apolipoproteins B (ApoB)IBA 01/2020
1	Proprotein Convertase 9IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Interleukin-7 (Interleukin 7)IBA 12/2019
1	Glucagon Receptors (Glucagon Receptor)IBA 11/2018
1	Monoclonal AntibodiesIBA 11/2018
1	RN909IBA 11/2018
1	2- (2- chloro- 4- fluorobenzyl)- 3- (4- fluorophenyl)- 7- (trifluoromethyl)- 2H- indazoleIBA 06/2009
1	Adenosine Triphosphate (ATP)IBA 06/2009
1	CholesterolIBA 06/2009
1	LigandsIBA 06/2009
1	HydrazinesIBA 03/2004
1	DNA (Deoxyribonucleic Acid)IBA 03/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2004
1	CalicheamicinsIBA 03/2004
1	Immunoconjugates (Immunoconjugate)IBA 03/2004
1	Inotuzumab OzogamicinIBA 03/2004
1	Gemtuzumab (Mylotarg)FDA Link 03/2004

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 03/2004